Acerus Announces Resignation of Director
26 Dezember 2022 - 1:00PM
Acerus Pharmaceuticals Corporation (the “
Company”
or “
Acerus”) (TSX: ASP; OTCQB: ASPCF) today
announced that Mr. Scott Leckie has resigned from the board of
directors of the Company, effective immediately.
About Acerus
Acerus Pharmaceuticals Corporation is a
specialty pharmaceutical company focused on the commercialization
and development of innovative prescription products that improve
patient experience, with a primary focus in the field of men’s
health.
Acerus’ shares trade on TSX under the symbol ASP
and on OTCQB under the symbol ASPCF. For more information, visit
www.aceruspharma.com and follow us on Twitter and LinkedIn.
Company ContactNaveed
ManzoorChief Financial Officerir@aceruspharma.com
Acerus Pharmaceuticals (TSX:ASP)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Acerus Pharmaceuticals (TSX:ASP)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
Echtzeit-Nachrichten über Acerus Pharmaceuticals Corporation (Toronto Börse): 0 Nachrichtenartikel
Weitere News-Artikel